FDA Brief

Warning letters Animal

FDA warning letter to

Ogle Cattle Company, Inc.

High riskIssued Sep 5, 2025Posted Sep 30, 2025Center for Veterinary Medicine

Ogle Cattle Company, a Texas feedlot, sold cattle for slaughter with ceftiofur residues above the allowed level and kept no treatment records.

What happened

FDA inspected the Bowie, Texas feedlot on April 17 and 18, May 6, and June 10, 2025, and issued a Form FDA 483 (a list of inspection observations) at the close; the company had not responded by the letter date. USDA testing of kidney tissue from four cattle the company sold at auction found desfuroylceftiofur (a marker for the antibiotic ceftiofur) at 9.44, 0.846, 2.04 and 0.520 ppm, all above the 0.4 ppm tolerance. FDA also found the company kept no identity records for animals bought or sold, no treatment records, and did not identify or separate treated animals.

What FDA found

  1. Cattle sold for slaughter had ceftiofur residue in kidney tissue well above the 0.4 ppm tolerance, making the meat adulterated (unsafe to eat).

    FD&C Act section 402(a)(2)(C)(ii) [21 U.S.C. § 342(a)(2)(C)(ii)]; 21 CFR 556.113(b)(1)(i)
  2. Animals were held without identity or treatment records and were not marked or separated after treatment, so medicated animals could reach the food supply.

    FD&C Act section 402(a)(4) [21 U.S.C. § 342(a)(4)]
  3. Staff gave ceftiofur by a route not on the approved label (under the skin of the neck or over the ribs), which is extralabel use.

    21 CFR 530.3(a); 21 CFR 530.41(a)(13)(ii)
  4. That extralabel use was not ordered by a licensed veterinarian within a valid veterinarian-client-patient relationship.

    FD&C Act section 512(a)(4)-(5); 21 CFR 530.3(i)(1)
  5. Shipping adulterated food in interstate commerce is a prohibited act.

    FD&C Act section 301(a) [21 U.S.C. § 331(a)]
  6. Enrofloxacin was used without records or separation of treated animals, and ciprofloxacin (its marker) was found in the cattle; enrofloxacin may not be used in an extralabel way.

    21 CFR 556.226(b)(1); 21 CFR 530.41(a)(10)

What FDA wants

Within 15 working days, tell FDA in writing what steps you have taken to fix each violation and prevent it from happening again, with supporting documents. If the fixes are not finished, explain why and give the date you expect to complete them.

Who should pay attention

  • feedlots and cattle producers who sell animals at auction
  • auction markets and packers that buy cattle from feedlots
  • veterinarians advising food-animal producers on drug use and withdrawal times

This is a summary. Read the original letter on fda.gov.

Similar letters to other companies

  1. Karcz Nation, LLC

    Wisconsin dairy farm sold cows for slaughter with illegal antibiotic residues after off-label ceftiofur and ampicillin use, FDA says.

    High risk
  2. John & Nicole Santos Dairy

    John & Nicole Santos Dairy of Hilmar, California sold dairy cows for slaughter containing ampicillin residues above the legal limit.

    High risk
  3. Wilson Livestock

    Wilson Livestock sold a heifer with excess desfuroylceftiofur residue and used a cephalosporin drug outside approved labeling for disease prevention.

    High risk
  4. Tex-Stein Dairy

    Tex-Stein Dairy sold a dairy cow for slaughter with illegal meloxicam and ceftiofur residues and kept incomplete treatment records.

    High risk